Otsuka Returns To Post-Traumatic Stress Disorder With Transcend Buyout

 
• By Joseph Haas
  
Ostuka holds to bolster its position in neurology with Transcend buyout (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business